Nokshimja Rasagiline Tablets 0.5 mg (Rasagiline Mesylate)
Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Nokshimja Co., Ltd.
MFDS item code 202002209 · Approved 2020.03.31
This product's status changed to Approval withdrawn on 2024.06.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of idiopathic Parkinson's disease
This is for the treatment of idiopathic Parkinson's disease. Initially, treatment begins with either monotherapy of a dopamine agonist or as an adjunct to a dopamine agonist. Subsequently, for patients exhibiting motor fluctuations, i.e., end of dose fluctuations, levodopa is used as an adjunct to manage symptoms. These treatments help improve the symptoms of Parkinson's disease and enhance the quality of life for patients.
This drug is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If it is well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1 mg once daily. This drug may be taken with or without food.
This medication should not be used by patients with an allergy to certain components. Additionally, patients who are currently taking or have recently stopped other MAO inhibitors, certain pain relievers, or cold medicines should not use this medication. Patients with moderate to severe liver impairment should also avoid this medication. This medication can cause various side effects, common symptoms include headache, dizziness, dermatitis, dyspepsia, insomnia, and arthralgia. Occasionally, severe symptoms such as depression, hallucinations, and blood pressure changes may also occur, so caution is necessary. If unusual skin reactions occur during treatment, consulting a specialist is recommended. Drowsiness or sudden sleep may occur while driving or operating machinery, so precaution is advised. Due to many potential drug interactions, any ongoing medications should be disclosed to a doctor or pharmacist. Caution is particularly warranted when taking this medication alongside antihypertensives, antidepressants, and pain relievers. Caution is also advised for use during pregnancy or breastfeeding, and consulting a specialist is important. Its safety and efficacy have not been established in children, so it is advisable not to use it. Serious side effects may occur in case of overdose, so it is important to adhere strictly to the prescribed dosage. Store in a cool place out of reach of children and do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, ideally at room temperature between 1 and 25 degrees Celsius. This will help maintain the medication's efficacy and ensure safe use.
Flat round tablets with a white or almost white appearance
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Nokshimja Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.